Gene Therapy May Be Long-Term Cure for Type of Hemophilia

THURSDAY, Jan. 2, 2020 — A new gene therapy appears to serve as a functional cure for the most common type of hemophilia, early clinical trial results indicate.
Patients who received the one-time intravenous therapy continue to have a more than 90%…
Source: Topamax